Imperial College London
Portrait Picture

ProfessorHolgerAuner

Faculty of Medicine, Department of Immunology and Inflammation

Visiting Professor
 
 
 
//

Contact

 

holger.auner04 Website

 
 
//

Assistant

 

Miss Mandy Sale +44 (0)20 3313 4017

 
//

Location

 

4N7ACommonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Mateos:2020:10.1182/blood-2020-137574,
author = {Mateos, M and Jagannath, S and Delimpasi, S and Simonova, M and Spicka, I and Pour, L and Kryachok, I and Gavriatopoulou, M and Dimopoulos, MA and Pylypenko, H and Auner, HW and Leleu, X and Doronin, VA and Usenko, G and Benjamin, R and Dolai, TK and Sinha, DK and Venner, CP and Garg, M and Stevens, DA and Quach, H and Moreau, P and Levy, MY and Badros, AZ and Anderson, LD and Bahlis, NJ and Facon, T and Cavo, M and Chai, Y and Arazy, M and Shah, J and Shacham, S and Kauffman, MG and Richardson, PG and Grosicki, S},
doi = {10.1182/blood-2020-137574},
publisher = {AMER SOC HEMATOLOGY},
title = {Impact of Prior Therapies on the Safety and Efficacy of Once Weekly Selinexor, Bortezomib, and Dexamethasone Compared with Twice Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Results from the Boston Study},
url = {http://dx.doi.org/10.1182/blood-2020-137574},
year = {2020}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Mateos,M
AU  - Jagannath,S
AU  - Delimpasi,S
AU  - Simonova,M
AU  - Spicka,I
AU  - Pour,L
AU  - Kryachok,I
AU  - Gavriatopoulou,M
AU  - Dimopoulos,MA
AU  - Pylypenko,H
AU  - Auner,HW
AU  - Leleu,X
AU  - Doronin,VA
AU  - Usenko,G
AU  - Benjamin,R
AU  - Dolai,TK
AU  - Sinha,DK
AU  - Venner,CP
AU  - Garg,M
AU  - Stevens,DA
AU  - Quach,H
AU  - Moreau,P
AU  - Levy,MY
AU  - Badros,AZ
AU  - Anderson,LD
AU  - Bahlis,NJ
AU  - Facon,T
AU  - Cavo,M
AU  - Chai,Y
AU  - Arazy,M
AU  - Shah,J
AU  - Shacham,S
AU  - Kauffman,MG
AU  - Richardson,PG
AU  - Grosicki,S
DO  - 10.1182/blood-2020-137574
PB  - AMER SOC HEMATOLOGY
PY  - 2020///
SN  - 0006-4971
TI  - Impact of Prior Therapies on the Safety and Efficacy of Once Weekly Selinexor, Bortezomib, and Dexamethasone Compared with Twice Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Results from the Boston Study
UR  - http://dx.doi.org/10.1182/blood-2020-137574
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000607547203056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER  -
Download